SCHEMBL9865836

SCHEMBL9865836

CC(C)(C)C(=O)Oc1ccc(-c2nsc(S(N)(=O)=O)n2)cc1

nearest known ligand 0.55

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CA2 P00918 9/20 0.55
ELANE P08246 10/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10641661 0.80 ADORA3 (0.42) CA2ELANE
SCHEMBL9868225 0.80 ADORA3 (0.42) CA2ELANE
SCHEMBL9867503 0.79 ADORA3 (0.52) CA2
SCHEMBL9867816 0.77 HSD17B1 (0.46) CA2
SCHEMBL9866517 0.76 CA2 (0.51) CA2
SCHEMBL9866053 0.74 CA2 (0.43) CA2
SCHEMBL9868652 0.74 SOS1 (0.50) CA2
SCHEMBL9867241 0.73 CYP2C9 (0.38) CA2
SCHEMBL9868097 0.73 CYP19A1 (0.58) CA2
SCHEMBL31531294 0.73 ELANE (0.74) CA2ELANE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4985450-A TREATMENT OF GLAUCOMA AVENTIS PHARMACEUTICALS INC. 1991-01-15 US claimed
US-4985450-A TREATMENT OF GLAUCOMA AVENTIS PHARMACEUTICALS INC. 1991-01-15 US disclosed
US-4873239-A GLAUCOMA TREATMENT HOECHST-ROUSSEL PHARMACEUTICALS, INC. (US) 1989-10-10 US disclosed
EP-0276822-A1 Arylthiadiazolylsulfonamides and derivatives, a process for their preparation and their use as medicaments HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1988-08-03 EP disclosed
US-4758578-A Arylthiadiazolylsulfonamides, pharmaceutical compositions and use HOECHST ROUSSEL PHARMACEUTICALS, INC. (US) 1988-07-19 US disclosed